COMMUNIQUÉS West-GlobeNewswire

Tokyo Smoke launches innovative educational events and resources

15/03/2018 - 20:14

TORONTO, March 15, 2018 (GLOBE NEWSWIRE) -- Tokyo Smoke , a subsidiary of Hiku Brands (“Hiku”) (CSE:HIKU), Canada’s first vertically-integrated cannabis brand house, is excited to announce ‘ Higher Learning ’, a brand- [...]

Bradmer Pharmaceuticals, Galaxy Digital and First Coin Announce Update

15/03/2018 - 19:58

TORONTO, March 15, 2018 (GLOBE NEWSWIRE) -- NOT FOR DISSEMINATION IN THE UNITED STATES OR FOR DISTRIBUTION TO U.S. NEWSWIRE SERVICES. Bradmer Pharmaceuticals Inc. (“ Bradmer ”) (TSX VENTURE:BMR.H), Galaxy Digital LP (“ [...]

Akers Biosciences Announces Conference Call to Discuss Fiscal Year 2017 Earnings

15/03/2018 - 18:11

THOROFARE, N.J, March 15, 2018 (GLOBE NEWSWIRE) -- Akers Biosciences, Inc. (NASDAQ: AKER) (AIM: AKR.L), (“Akers Bio” or the "Company"), a developer of rapid health information technologies, will hold a conference call [...]

OSE Immunotherapeutics Receives Approval in Europe to Resume Patient Accrual for Phase 3 Tedopi® Clinical Trial in Advanced Non-Small Cell Lung Cancer Patients Following Immune Checkpoint Inhibitor Treatment

15/03/2018 - 18:00

Phase 3 Trial received Approval to be Initiated in Israel Patient Accrual Already Resumed in the U.S. NANTES, France, March 15, 2018 (GLOBE NEWSWIRE) -- OSE Immunotherapeutics (ISIN:FR0012127173) (Mnémo:OSE), today [...]

ThromboGenics Business Update - FY 2017

15/03/2018 - 17:41

Press release 15 March 2018 Regulated Information Advancing Preclinical and Clinical Diabetic Eye Disease Portfolio Regained global rights to JETREA ® from Alcon, a Novartis company, and received €53.7 million in cash [...]

Elsalys Biotech : LEUKOTAC at the 44th congress of the European Society for Blood and Marrow Transplantation (EBMT)

15/03/2018 - 17:08

LEUKOTAC ® at the 44 th congress of the European Society for Blood and Marrow Transplantation (EBMT) A poster summarising the safety profile results of the randomised Phase 3 testing LEUKOTAC® in patients with steroid- [...]

Elsalys Biotech : LEUKOTAC® au 44ème congrès européen de greffe de moelle (EBMT)

15/03/2018 - 17:08

LEUKOTAC ® au 44 ème congrès européen de greffe de moelle (EBMT) Un poster résumant les résultats sur le profil de sécurité de la Phase 3 randomisée testant LEUKOTAC® chez les patients atteints d'une forme aigüe et [...]

Arbor Biotechnologies Discovers New CRISPR System Utilizing its Discovery Platform

15/03/2018 - 17:00

Findings Published in the Journal Molecular Cell $15 Million Series A Financing to Scale Biodiscovery CAMBRIDGE, Mass., March 15, 2018 (GLOBE NEWSWIRE) -- Arbor Biotechnologies, an early stage life sciences company, [...]

The Cancer Research Collaboration and Breastlink New York Partner With Diabetes Prevention Program Provider Blue Mesa Health

15/03/2018 - 15:56

NEW YORK, March 15, 2018 (GLOBE NEWSWIRE) -- The Cancer Research Collaboration (CRC), a non-profit organization dedicated to expanding the availability of cutting-edge cancer research, and Breastlink New York, a leader [...]

Medinas Health Closes $1 Million Seed Round Co-led by Ashton Kutcher & Guy Oseary's Sound Ventures and General Catalyst’s Rough Draft Ventures

15/03/2018 - 15:13

SAN FRANCISCO, March 15, 2018 (GLOBE NEWSWIRE) -- Medinas Health – a data-driven marketplace helping healthcare organizations safely and securely buy and sell their surplus and short-date medical supplies and equipment [...]

Inivata: Inivata Announces Collaboration with MedStar Health to Utilize Liquid Biopsy to Advance Precision Cancer Genomics

15/03/2018 - 15:12

Inivata Announces Collaboration with MedStar Health to Utilize Liquid Biopsy to Advance Precision Cancer Genomics MedStar and the MedStar Georgetown Cancer Institute to Join the Inivata Knowledge Accumulation Network ( [...]

Sienna Announces March Dividend

15/03/2018 - 15:00

MARKHAM, Ontario, March 15, 2018 (GLOBE NEWSWIRE) -- Sienna Senior Living Inc. (“ Sienna ” or the “ Company ”) (TSX: SIA ) today announced a dividend of $0.075 per common share of the Company (each, a “Common Share”) [...]

Invuity Announces Pricing of Public Offering of Common Stock

15/03/2018 - 14:47

SAN FRANCISCO, March 15, 2018 (GLOBE NEWSWIRE) -- Invuity, Inc . (NASDAQ: IVTY ) (“Invuity” or the “Company”), a leading medical technology company focused on minimal access surgery, today announced the pricing of its [...]

PotNetwork Holding Inc Generates Over $2 Million in Sales Revenue for February 2018, a 480% Increase on Last Year

15/03/2018 - 14:07

FORT LAUDERDALE, Fla., March 15, 2018 (GLOBE NEWSWIRE) -- Via OTC PR Wire -- PotNetwork Holding, Inc (OTCPink:POTN ) announced today that its wholly owned subsidiary, Diamond CBD, Inc., has generated over 2 million [...]

HealthLynked Corp. Announces Formation of its Health Advisory Board

15/03/2018 - 14:07

NAPLES, Fla., March 15, 2018 (GLOBE NEWSWIRE) -- HealthLynked Corp. (OTCQB:HLYK) today announced the formation of its Health Advisory Board (HAB). The HAB is comprised of Healthcare providers from a range of medical [...]

Sienna Biopharmaceuticals Reports Fourth Quarter and Full Year 2017 Financial Results

15/03/2018 - 14:05

-- Pipeline Includes Five Clinical-Stage Programs -- Data from Five Clinical Programs Expected, Beginning in 2H18 WESTLAKE VILLAGE, Calif., March 15, 2018 (GLOBE NEWSWIRE) -- Sienna Biopharmaceuticals, Inc. (NASDAQ: [...]

Ceapro to Present at the Wall Street Investor Forum

15/03/2018 - 14:00

EDMONTON, Alberta, March 15, 2018 (GLOBE NEWSWIRE) -- Ceapro Inc. (TSX-V: CZO ) (“Ceapro” or the “Company”), a growth-stage biotechnology company focused on the development and commercialization of active ingredients [...]

MRI Interventions, Inc. Reports 34% Year-Over-Year Increase in Functional Neurology Revenues, 50% increase in Capital Sales

15/03/2018 - 14:00

Record 629 ClearPoint ® Procedures Performed in 2017 New Initiatives Position for Further Growth in 2018 IRVINE, Calif., March 15, 2018 (GLOBE NEWSWIRE) -- MRI Interventions, Inc. (OTCQB:MRIC) (the “Company”) today [...]

Adamas Announces Publication of Data Supporting the Benefits of GOCOVRI™ in Parkinson’s Disease Patients with Dyskinesia

15/03/2018 - 14:00

EMERYVILLE, Calif., March 15, 2018 (GLOBE NEWSWIRE) -- Adamas Pharmaceuticals, Inc. (Nasdaq: ADMS ) today announced that pooled Phase 3 data of GOCOVRI™ (amantadine) extended release capsules for the treatment of [...]